ArticleBMB reports2018

MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis.

Zhiguo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.